Copyright Reports & Markets. All rights reserved.

Global and China Tyrosine Kinase Inhibitors Market Research by Company, Type & Application 2013-2025

Buy now

Table of Content

    1 Market Overview

    • 1.1 Market Segment Overview
      • 1.1.1 Product Definition
      • 1.1.2 Market by Type
        • 1.1.2.1 BCR-ABL Tyrosine Kinase Inhibitor
        • 1.1.2.2 Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
        • 1.1.2.3 Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors
      • 1.1.3 Market by Application
        • 1.1.3.1 Chronic Myeloid Leukemia (CML)
        • 1.1.3.2 Lung Cancer
        • 1.1.3.3 Breast Cancer
        • 1.1.3.4 Renal Cell Cancer
        • 1.1.3.5 Others
    • 1.2 Global and China Market Size
      • 1.2.1 Global Overview
      • 1.2.2 China Overview

    2 Global and China Market by Company

    • 2.1 Global
      • 2.1.1 Global Sales by Company
      • 2.1.2 Global Price by Company
    • 2.2 China
      • 2.2.1 China Sales by Company
      • 2.2.2 China Price by Company

    3 Global and China Market by Type

    • 3.1 Global
      • 3.1.1 Global Sales by Type
      • 3.1.2 Global Price by Type
    • 3.2 China
      • 3.2.1 China Sales by Type
      • 3.2.2 China Price by Type

    4 Global and China Market by Application

    • 4.1 Global
      • 4.1.1 Global Sales by Application
      • 4.1.2 Global Price by Application
    • 4.2 China
      • 4.2.1 China Sales by Application
      • 4.2.2 China Price by Application

    5 China Trade

    • 5.1 Export
    • 5.2 Import

    6 Key Manufacturers

    • 6.1 AstraZeneca
      • 6.1.1 Company Information
      • 6.1.2 Product Specifications
      • 6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.2 Pfizer
    • 6.3 Novartis
    • 6.4 Bristol-Myers Squibb
    • 6.5 Bayer
    • 6.6 Boehringer Ingelheim International
    • 6.7 F. Hoffmann-La Roche
    • 6.8 Johnson & Johnson
    • 6.9 Eisai

    7 Industry Upstream

    • 7.1 Industry Chain
    • 7.2 Raw Materials

    8 Market Environment

    • 8.1 SWOT
    • 8.2 Porter's Five Forces

    9 Conclusion

    Summary

    Market Segment as follows:
    By Type
    BCR-ABL Tyrosine Kinase Inhibitor
    Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
    Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors
    By Application
    Chronic Myeloid Leukemia (CML)
    Lung Cancer
    Breast Cancer
    Renal Cell Cancer
    Others
    By Company
    AstraZeneca
    Pfizer
    Novartis
    Bristol-Myers Squibb
    Bayer
    Boehringer Ingelheim International
    F. Hoffmann-La Roche
    Johnson & Johnson
    Eisai
    The main contents of the report including:
    Section 1:
    Product definition, type and application, global and China market overview;
    Section 2:
    Global and China Market competition by company;
    Section 3:
    Global and China sales revenue, volume and price by type;
    Section 4:
    Global and China sales revenue, volume and price by application;
    Section 5:
    China export and import;
    Section 6:
    Company information, business overview, sales data and product specifications;
    Section 7:
    Industry chain and raw materials;
    Section 8:
    SWOT and Porter's Five Forces;
    Section 9:
    Conclusion.

    Buy now